Economic Impact of Intensifying Basal Insulin with Insulin Aspart among Patients with Type 2 Diabetes: A US Real-World Study

被引：0
|
作者：
Sun, Peter
Lian, Jean
Karolicki, Boris
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1152-P
引用
收藏
页码：A299 / A300
页数：2
相关论文
共 50 条
  • [1] Real-world comparative outcomes study in US patients with type 2 diabetes initiating basal insulin analogues
    Davis, K. L.
    Meyers, J. L.
    Tangirala, M.
    Wei, W.
    [J]. DIABETOLOGIA, 2012, 55 : S384 - S384
  • [2] Real-World Assessment of Clinical Effectiveness when Switching to Insulin Degludec from Another Basal Insulin among Type 2 Diabetes Patients in the US
    Tibaldi, Joseph M.
    Hansen, Brian B.
    Wolden, Michael L.
    Moralea, Maria E.
    Yue, Yinan
    Weatherall, James
    Rodbard, Helena W.
    [J]. DIABETES, 2017, 66 : A261 - A261
  • [3] Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy
    Davis, Keith L.
    Tangirala, Muralikrishna
    Meyers, Juliana L.
    Wei, Wenhui
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (09) : 1083 - 1091
  • [4] Clinical and economic outcomes among injection-naive patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study
    Mody, Reema
    Huang, Qing
    Yu, Maria
    Patel, Hiren
    Zhang, Xian
    Wang, Liya
    Grabner, Michael
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [5] Incidence of hypoglycaemia in patients with type 2 diabetes mellitus recently initiating basal insulin in a real-world US setting
    Kazemi, M.
    Ye, F.
    Dalal, M. R.
    [J]. DIABETOLOGIA, 2015, 58 : S458 - S458
  • [6] First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
    Tsai, Shih-Tzer
    Pathan, Faruque
    Ji, Linong
    Yeung, Vincent Tok Fai
    Chadha, Manoj
    Suastika, Ketut
    Son, Hyun Shik
    Tan, Kevin Eng Kiat
    Benjasuratwong, Yupin
    Thy Khue Nguyen
    Iqbal, Farrukh
    [J]. JOURNAL OF DIABETES, 2011, 3 (03) : 208 - 216
  • [7] Assessment of real-world efficacy and safety of basal insulin plus rapid-acting insulin vs basal insulin treatment among patients with type 2 diabetes in the UK
    Lin, J.
    Jhaveri, M.
    Liao, L.
    Kitio-Dschassi, B.
    Lingohr-Smith, M.
    [J]. DIABETOLOGIA, 2015, 58 : S76 - S77
  • [8] Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study
    Bellido, Diego
    Abellan, Pablo
    Palomar, Jose Manuel Ruiz
    Sintes, Rogelio Alvarez
    Nubiolae, Andreu
    Bellido, Virginia
    Romero, Gracia
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2018, 89 : 37 - 42
  • [9] REAL-WORLD ECONOMIC OUTCOMES AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) TREATED WITH DULAGLUTIDE (DU) VS. BASAL INSULIN (BI) IN THE US: THE DISPEL™ STUDY
    Mody, R.
    Huang, Q.
    Yu, M.
    Zhang, X.
    Wang, L.
    Grabner, M.
    Patel, H.
    [J]. VALUE IN HEALTH, 2019, 22 : S149 - S150
  • [10] Much Ado About Nothing? A Real-World Study of Patients with Type 2 Diabetes Switching Basal Insulin Analogs
    Wenhui Wei
    Steve Zhou
    Raymond Miao
    Chunshen Pan
    Lin Xie
    Onur Baser
    Jasvinder Gill
    [J]. Advances in Therapy, 2014, 31 : 539 - 560
12345